Indication
Coronary Artery Bypass
5 clinical trials
5 products
1 drug
Clinical trial
The Effect of Two Different Rates of Nitroglycerin Infusion on Cerebral Rewarming During Rewarming Period of Hypothermic Cardiopulmonary BypassStatus: Completed, Estimated PCD: 2017-11-22
Product
Glyceryl trinitrateClinical trial
Role of Glutamine as Myocardial Protector in Elective On-Pump Coronary Artery Bypass Graft Surgery With Low Ejection FractionStatus: Completed, Estimated PCD: 2021-10-30
Product
L-alanyl-L-glutamineDrug
VarlilumabClinical trial
Evaluation of the Efficacy of Different Duration of a Proton Pump Inhibitor in the Prevention of Upper Gastrointestinal Mucosal Injury in Patients Taking 12-month Dual Antiplatelet Therapy After Coronary Artery Bypass GraftingStatus: Active (not recruiting), Estimated PCD: 2023-12-30
Product
PantoprazoleClinical trial
Colchicine in Patients Undergoing Coronary Artery Bypass Grafting After Acute Coronary Syndrome: an Open-label Randomized TrialStatus: Recruiting, Estimated PCD: 2025-02-05
Product
ColchicineClinical trial
Phase III Study of Intravenous Glutamate Infusion for Metabolic Protection of the Heart in Surgery for Unstable Coronary Artery DiseaseStatus: Completed, Estimated PCD: 2009-12-01
Product
saline